UGA spinout Aruna Bio is working on a treatment for neurodegenerative diseases such as Parkinson’s and multiple sclerosis.
Aruna Bio, a US-based developer of neural exosomes to treat neurogenerative diseases that is based on research at University of Georgia, has completed a $10.8m funding round featuring unnamed new and existing backers.
Aruna Bio’s neural exosomes are being developed both as a stand-alone therapeutic and as a delivery vehicle that can reach the brain and central nervous system. It is targeting neurodegenerative diseases, potentially including Parkinson’s, multiple sclerosis and stroke.
The company hopes to submit its first…
